RELATED CONTENT
NEWS
- Roche expands hepatitis C deal with Merck after Victrelis' EU nod
- Bayer/J&J report positive Xarelto results in Japanese AF patients
- Allos' Folotyn extends PFS and defers resistance to other drugs in lymphoma
- Biogen/Elan hope updated Tysabri label will lend confidence to patients/prescribers

